News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Phase 1 data from the auristatin HER2 ADC PF-06804103 highlight the importance of optimizing the toxicity profile of novel ADCs – Paolo Tarantino
Photo from Paolo Tarantino/Twitter
Jul 9, 2023, 09:59

Phase 1 data from the auristatin HER2 ADC PF-06804103 highlight the importance of optimizing the toxicity profile of novel ADCs – Paolo Tarantino

Phase 1 data from the auristatin HER2 ADC PF-06804103 highlight the importance of optimizing the toxicity profile of novel ADCs. The drug showed relevant activity (ORR 30%) for HER2+ BC & GC, but nearly half of the pts discontinued treatment for toxicity.

For article: Click here

Source: Paolo Tarantino/Twitter

#cancer patients auristatin cancer drug OncoDaily Oncology Paolo Tarantino toxicity
Special Coverage
Insight
Dec 25, 2024, 03:00
Mazyar Shadman: Venetoclax - based therapy after cBTKi in CLL led by Nilanjan Ghosh
Insight
Dec 25, 2024, 02:57
Jarushka Naidoo: Important paper on incidence and outcomes of EGFR+ NSCLC
Insight
Dec 25, 2024, 02:41
Correlating PSA Dynamics with Outcomes of Lutetium-177-PSMA-617 Treatment - European Urology
Science
Dec 25, 2024, 02:35
Hospital Participation in the Acute Hospital Care at Home Waiver Program by Hashem Zikry et al.
Science
Dec 25, 2024, 01:52
Erman Akkus: Role of PD-L1 expression in advanced esophageal SCC by Manavi Sachdeva et al.
Blog
Dec 25, 2024, 01:50
Results of SISAQOL-IMI: Advancing Patient-Reported Outcomes Research
Science
Dec 24, 2024, 23:45
Tatiana Prowell: Genomic profiling performed on 822 breast cancer brain metastases by Athina Giannoudis et al.
Blog
Dec 24, 2024, 23:42
Extending the pandemic-era telehealth flexibilities in Medicare - ASCO
Science
Dec 24, 2024, 23:36
Drew Moghanaki: An updated report from the MISSILE study team
Science
Dec 24, 2024, 23:31
Bladder-sparing Therapy for BCG-unresponsive Non-muscle-invasive Bladder Cancer
Insight
Dec 24, 2024, 23:29
Mark Bolton: What if patients switch treatment at progression
Blog
Dec 24, 2024, 23:27
Give the gift of hope, brighter futures, and more time for patients and families - The Leukemia And Lymphoma Society